A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel

Clinical trial NCT01949324 · COMPLETED

Trial details

NCT number: NCT01949324
Sponsor: Neurotech Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Macular Telangiectasia Type 2

Start date: 2014-04-01
Primary completion: 2017-04-14
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.